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Abstract
The intervertebral disc (IVD) is a complex tissue, and its degeneration remains a problem for patients, without 
significant improvement in treatment strategies. This mostly age-related disease predominantly affects the 
nucleus pulposus (NP), the central region of the IVD. The NP tissue, and especially its microenvironment, 
exhibit changes that may be involved at the outset or affect the progression of IVD pathology. The NP tissue 
microenvironment is unique and can be defined by a variety of specific factors and components characteristic 
of its physiology and function. NP progenitor cell interactions with their surrounding microenvironment 
may be a key factor for the regulation of cellular metabolism, phenotype, and stemness. Recently, cell-
transplantation approaches have been investigated for the treatment of degenerative disc disease, highlighting 
the need to better understand if and how transplanted cells can give rise to healthy NP tissue. Hence, 
understanding all the components of the NP microenvironment seems to be critical to better gauge the success 
and outcomes of approaches for tissue engineering and future clinical applications. Knowledge about the 
components of the NP microenvironment, how NP progenitor cells interact with them, and how changes 
in their surroundings can alter their function is summarised. Recent discoveries in NP tissue engineering 
linked to the microenvironment are also reviewed, meaning how crosstalk within the microenvironment 
can be adjusted to promote NP regeneration. Associated clinical problems are also considered, connecting 
bench-to-bedside in the context of IVD degeneration.
Keywords: Tissue engineering, regenerative medicine, intervertebral disc, nucleus pulposus, cell therapy, 
microenvironment, clinical research.
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list of Abbreviations
2D   2-dimensional
3D   3-dimensional
ADSC  adipose-derived stromal cell
AF   annulus fibrosus
AMPC  allogeneic mesenchymal precursor cell
API  recombinant human growth and   
   differentiation factor-5 (aka. rhGDF-5)
ASC  adipose stromal cell
BMAC  bone marrow aspirate concentrate
BMP  bone morphogenetic protein
BMSCs   bone marrow/mesenchymal stem/  
   stromal cells
CCL-5  chemokine (C-C motif)
CD202b  angiopoietin-1 receptor 
CD24  cluster of differentiation 24
CEP  cartilaginous endplate
CFU-f  colony forming units-fibroblast
CT   computed tomography
CTGF  connective tissue growth factor
DDD  degenerative disc disease 
DPQ  Dallas pain questionnaire
ECM  extracellular matrix
EQ5D  standardised measure of health-related  
   quality of life developed
ES   embryonic stem
FGF  fibroblast growth factor
FRI  functional rating index
GAG  glycosaminoglycan
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GD2  disialoganglioside 2
GDF  growth and differentiation factor
GLUT-1  glucose transporter 1
GMP  good manufacturing practice
HIF-1α  hypoxia-inducible factor 1α
IDCT  injectable disc cell therapy
IDD  intervertebral disc degeneration
IGF  insulin growth factor
IL   interleukin
iPSC  induced pluripotent stem cell
IVD  intervertebral disc
JOABPEQ Japanese orthopaedic association back  
   pain evaluation questionnaire
LBP  low-back pain
LDD  lumbar disc degeneration/disease
MB   methylene blue
MMP  matrix metalloproteinase
MODISC  Modic I discopathies
MPC  mesenchymal precursor cell
MRI  magnetic resonance imaging
MSC  mesenchymal stromal cell
MSV  GMP)-compliant expanded bone   
   marrow MSC (MSV, PEI Num. 10-134)
Nanog  homeobox protein NANOG 
NASS  North American Spine Society
NF-κB  nuclear factor kappa-light-chain-  
   enhancer of activated B cells
Notch1  notch homolog 1, translocation-  
   associated
NP   nucleus pulposus
NRS  numerical rating scale
Oct4  octamer-binding transcription factor 4
ODI  Oswestry disability index
PASS  patient acceptable symptom state
PDGF  platelet derived growth factor 
PEG  polyethylene glycol
pNIPAM  poly(N-isopropylacrylamide)
PROMIS  patient-reported outcomes   
   measurement information system
PRP  platelet-rich plasma
RCT  randomised-controlled trial
rhGDF-5  recombinant human growth and   
   differentiation factor-5
RMQ  Roland-Morris questionnaire
SAPH  self-assembling peptide hydrogel
SF   short form
SIRT1  NAD-dependent deacetylase sirtuin-1
SIRT6  NAD-dependent deacetylase sirtuin-6
SLRP  small leucine-rich proteoglycan
SOX9  SRY-box transcription factor 9
TAA   triamcinolone acetonide
TGF-β1  transforming growth factor- β1
Tie2  TEK receptor tyrosine kinase
TNF-α  tumour necrosis factor-α
VAS  visual analogue scale
VAST  viable allograft supplemented disc   
   regeneration treatment 
WPAI   work productivity and activity index
introduction
The IVD can be defined as a joint between adjacent 
vertebral bodies. It is composed of three primary 
tissues, the NP, the AF, and the CEP (Urban and 
Roberts, 2003). The cells within each of the regions 
of the IVD can not only be subjected to physical and 
biochemical stimuli from their ECM but also from 
their surrounding microenvironment (i.e. non-ECM 
related) (Baer et al., 2003; Cao et al., 2009; Cao et al., 
2011; Hsieh et al., 2005; Hwang et al., 2014; Jackson 
et al., 2011a; Korecki et al., 2008). Moreover, it is well 
documented that disc degeneration first occurs in 
the NP region of the IVD (Wang et al., 2014; Zhao et 
al., 2007). In this context, this full microenvironment 
(i.e. ECM and non-ECM related factors) of the 
IVD, and especially the NP microenvironment is 
believed to play a critical role in the regulation and 
maintenance of this tissue. It can potentially improve 
the repair and regeneration of the vertebral column 
joint (Fig. 1). However, the understanding of the NP 
microenvironment of the IVD is still incomplete.
 In this review, papers reporting NP cell interactions 
with their surrounding microenvironment have been 
summarised to help improve future development 
of tissue engineering and regenerative medicine 
approaches. The first section covers what has been 
have learned from the current literature on:
• the  “genera l”  compos i t ion  o f  the  NP 
microenvironment with the description of 
essential components (non-ECM and ECM-
related),
• how NP cells interact with their native 
microenvironment,
• how changes in the surrounding, particularly due 
to degeneration or disease, can alter NP cells. 
• the state-of-the-art for tissue engineering and 
regenerative medicine approaches using this 
knowledge to treat IVD degeneration and LBP.
• clinical trials involving and targeting the NP 
microenvironment and how all the available 
expertise was used to bring bench and bedside 
closer together.
The “general” composition of the np 
microenvironment
non-eCm-related factors
The IVD is an avascular tissue. Therefore, the 
supply of nutrition to the disc primarily occurs 
through diffusion from its surrounding vasculature 
(Jackson et al., 2011b). The variation between cellular 
consumption rates and nutrient transport (passive 
or active) leads to concentration gradients of these 
metabolites and nutrients throughout the IVD. 
Consequently, this markedly affects the viability, 
proliferation, and function of cells, and collectively 
will alter any subsequent potential regeneration or 
repair.
 In human lumbar, thoracic, and cervical discs, 
oxygen levels vary considerably and do not appear 
to correlate with ageing or the degree of severity 
of pathological disease such as disc degeneration. 
Oxygen concentrations decrease from the AF across 
the disc inner structure (between 19.5 % and 0.65 %) 
with average normoxic levels in the central part of 
the NP being between 0.5 % and 10 % of oxygen 
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(Bartels et al., 1998; Buckley et al., 2018). These levels 
are mainly determined by the transport through the 
CEP, but also by the cellular density within the tissue, 
and the cellular consumption rates.
 Another critical point of the microenvironment 
is the presence/absence of the most used “fuel” in 
the body, glucose. It is well recognised that NP cell 
viability is reduced if the microenvironment is glucose 
deficient. However, a low oxygen concentration 
within the microenvironment has not been shown 
to be detrimental to NP cell viability. Glucose level 
does play a critical role as a limiting factor for disc-cell 
survival (Urban et al., 2004). A mathematical model 
has predicted a decrease in glucose concentrations, 
from around 5 mmol/L in the AF to approximately 
0.8 mmol/L, in the NP tissue part of healthy IVDs 
(Selard et al., 2003) that can even fall below critical 
levels with more substantial calcification of the CEP 
tissue (Jackson et al., 2011b). Importantly, cell death 
can already occur when cells are subjected to glucose 
concentrations below 0.5 mmol/L for more than 3 d 
(Horner and Urban, 2001). Additionally, low cell 
viability correlates with low glucose concentrations, 
which has been shown in scoliotic discs (Bibby et al., 
2002).
 Another important parameter in the NP tissue 
microenvironment is the pH. The pH ranges from 2 to 
6, which is mainly due to the local production of lactic 
acid, as a result of glycolysis by the IVD cells (Bartels 
et al., 1998). Several in vivo measurements revealed pH 
ranges from 5.7 to 7.5 (with a median at 7.0) (Bez et al., 
2018; Gilbert et al., 2016; Nachemson, 1969). It is well 
established that the pH can significantly influence 
cell survival, negatively affect matrix synthesis rates 
(Horner and Urban, 2001; Ohshima and Urban, 
1992), but may also increase the expression of pro-
inflammatory cytokines and pain-related factors in 
the context of LBP (Gilbert et al., 2016). Furthermore, 
scientists found that rates of metabolism (e.g. 
oxygen consumption) were sensitive and coupled 
in a non-linear way with the pH present in the 
microenvironment of bovine discs (Bibby et al., 2005).
 The physiological mechanical loading stress 
of the IVD tissue leads to constant exposure of 
the IVD cells to high osmolarity and, therefore, 
microenvironmental osmotic changes (Sadowska 
et al., 2018). Aggrecan, as a cartilage-specific 
proteoglycan is essential for maintaining hydration 
and hence osmotic pressure in the IVD (Urban and 
Roberts, 2003). Negatively charged GAGs regulate 
the ionic balance of the IVD ECM (Johnson et al., 
2014). Aggrecan is linked to sulphated GAGs (e.g. 
keratan and chondroitin sulphate). They can create 
a negative charge and hence bind water within the 
tissue. If this is transposed to the tissue level, the 
generation of osmotic pressure in the IVD creates a 
water “flow” into the NP tissue. This water intake 
also leads to the load-bearing ability and the crucial 
swelling pressure of the IVD (Erwin and Hood, 2014; 
Urban and Maroudas, 1981; Urban et al., 1979; Urban 
and Roberts, 2003). In a healthy state, the extracellular 
osmolarity can vary from around 430 mOsm/L (iso-
osmotic pressure) to around 496 mOsm/L (hyper-
osmotic pressure) (Ishihara et al., 1997; van Dijk et 
al., 2011). These values are in a physiological range 
for IVD cells but would be considered too high or 
too variable if compared to the osmotic pressure 
that most mammalian cells experience (Appelboom 
fig. 1. The fountain of youth. How the NP microenvironment and how factors involved in it can implement 
tissue engineering approaches for the regeneration of the IVD and therefore enable future clinical improvement. 




Regenerative medicine approaches using
microenvironment components
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et al., 1956; Brocker et al., 2012). As a reference, the 
osmotic pressure of healthy blood ranges between 
280 mOsm/L and 320 mOsm/L (Neidlinger-Wilke 
et al., 2012). In a diseased state (e.g. degenerated), 
the IVD osmolarity can even decrease so much that 
it reaches values of around 300 mOsm/L (hypo-
osmotic pressure), due to a loss of proteoglycans 
(Wuertz et al., 2007). As a result, IVD hydration can 
be compromised, and fibrosis may occur. However, 
this hypo-osmotic pressure would be considered 
physiological for cells of other tissues, especially 
in older people (Hooper et al., 2015). Nevertheless, 
stem-cell-related research and associated publications 
discussing high osmolarities are still limited. Tao 
et al. (2013) pioneered the analysis of the effect of 
osmotic pressure on IVD progenitor cells. They 
found that high osmolarity could not only decrease 
the viability and proliferation of IVD cells but also 
affect the expression levels of collagen type II, SOX-9 
transcription factor, and aggrecan in NP progenitor 
cells (Tao et al., 2013). Additionally, a study showed 
the effects of high osmolarity on human ADSCs in 
the context of IVD regeneration (Liang et al., 2012a). 
They concluded that high osmolarity in the IVD 
microenvironment is a deleterious factor that affects 
the survival and biological behaviour of ADSCs, 
making them less suitable for clinical applications. 
A recent bioinformatic analysis identified significant 
gene biomarkers of LBP caused by changes in the 
osmotic pressure of NP cells, providing a reference 
for future in-depth research (Zhao et al., 2020).
 In the context of regenerative medicine or 
tissue engineering, all 4 components of the 
microenvironment described above (oxygen, 
glucose, pH, and osmolarity) seem to have a different 
impact on the IVD cells (Fig. 2). On the one hand, 
oxygen concentration appears to have a pivotal role 
in regulating the biosynthesis and phenotype of 
targeted cells for therapeutic applications (Naqvi 
and Buckley, 2015). On the other hand, low glucose 
concentrations, osmolarity, and low pH levels can 
impair the survival and biological behaviour of 
progenitor cells (Li et al., 2012; Naqvi and Buckley, 
2016; Tao et al., 2013; Wuertz et al., 2009). All those 
parameters (non-ECM related) should be taken into 
account in the development of future approaches 
to tissue engineering and regenerative medicine 
targeting IVD and especially NP tissue.
eCm-related factors
The IVD ECM can be characterised as a scaffold rich 
in molecules that offer structural and biochemical 
support to the resident cells (Fig. 3). The structural, 
and indeed functional requirements, determine the 
mechanical properties of the ECM, which depend on 
the protein composition of the matrix – particularly 
the percentage and type of several collagens and 
elastin fibres (Mercuri et al., 2014; Sivan et al., 2014a). 
Furthermore, the biochemical and physiological 
relevance of these properties is illustrated by a 
mutual/reciprocal crosstalk between ECM and 
cells. Cells are capable of sensing surrounding ECM 
stiffness thanks to integrin-mediated interactions 
with the matrix (Gilchrist et al., 2007). The mechanical 
properties of the ECM are then interpreted and can 
affect cell motility, proliferation, differentiation, and 
apoptosis (Newell et al., 2019; Peng et al., 2020). Hence, 
knowledge of the precise composition of IVD tissues 
is critical to the understanding of their physiology 
and physiopathology. For example, the most common 
pathological state of the IVD (degenerated) is often 
closely related to alterations in the composition and 
structure of the ECM. Degeneration of the IVD tissue 
is well known to be linked with excessive matrix 
catabolism (Roughley, 2004).
 The protein composition of human IVD tissues 
fig. 2. summary of non-eCm-related components and their ranges within the np microenvironment. 
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will now be examined, to better estimate the amount 
of ECM proteins present both in a healthy and 
disease state. In terms of percentage, the ECM is 
mainly composed of water (70-90 % of wet weight), 
followed by proteoglycans (65 % of dry weight), and 
collagen type II (15-20 % of dry weight) (Eyre and 
Muir, 1977; Gower and Pedrini, 1969). Other minor 
components (though potentially critical functionally) 
of the NP ECM include elastin, small proteoglycans, 
other collagens (types III, VI, IX) (Melrose et al., 2001; 
Roberts et al., 1991; Yu, 2002), and laminins (Chen et 
al., 2009; Gilchrist et al., 2007; Nettles et al., 2004). IVD-
ECM contains 385 ± 35 μg of collagen (all types) per 
mg of dry tissue. Its abundance is not significantly 
affected by age or sex. But, the amount of collagen is 
slightly different between the AF and NP, with the 
AF tissue having significantly more collagen than NP 
tissue. All publications on the topic, conclude that the 
dry weight of the NP tissue has more proteoglycans 
than AF tissue (Choi, 2009; Mwale et al., 2011). 
Concerning other main components of the IVD ECM, 
the total amount of proteoglycans in human tissue is 
144 ± 16 μg per mg of dry tissue, and for elastin the 
amount is approximately 18 ± 4.1 μg per mg of dry 
tissue (McKee et al., 2019). However, in a pathological 
context (e.g. scoliosis or disc degeneration), changes 
to ECM composition can occur, particularly in 
the percentage of collagen (McKee et al., 2019). 
Furthermore, an increase in elastin is also observed 
in degenerated IVD (McKee et al., 2019).
 The protein composition of the ECM is a 
powerful regulator of cellular behaviour (Yue, 2014). 
Consequently, failure to adequately mimic the native 
extracellular environment during in vitro cell culture 
processes may lead to altered proliferation, adhesion, 
migration, polarity, differentiation, and apoptosis of 
the targeted cells. In the context of a clinical trial, in 
vitro results may not translate into the human patient 
(Edmondson et al., 2014). To become closer to the 
native microenvironment, culturing on ECM-coated 
dishes, within 2D or even 3D culture, on biomimetic 
scaffolds, or organ-like/organoids culture has become 
a more and more common practice to overcome 
these unwanted artificial effects (Edmondson et 
al., 2014; Guerrero et al.; Huch and Koo, 2015). By 
precisely summarising an “ingredient list” for the 
microenvironment it should be possible to recreate 
models that mimic it, and further improve knowledge 
through more efficient in vitro tools.
how np progenitor cells interact with their 
microenvironment
IVD degeneration does not generally occur because 
of a single factor, but rather because of a variety 
of them. Usually, it is attributed to a complex 
interplay between environmental, genetic factors and 
mechanical damage (Dudli et al., 2012; Kalichman and 
Hunter, 2008; Kamper et al., 2016; Livshits et al., 2011; 
Mayer et al., 2013; Silva and Holguin, 2020). However, 
each of these factors leads to a final typical result 
of imbalance between the anabolic and catabolic 
microenvironment of the NP tissue in favour of 
catabolism.
 During disc degeneration or just simply during 
ageing, significant changes can occur in the ECM 
composition and structure and, therefore, have an 
impact on IVD cell behaviour. All these changes that 
drastically affect the IVD microenvironment lead to an 
important decrease in cell density, and cell clustering 
(Boos et al., 2002; Hastreiter et al., 2001; Johnson et al., 
2001; Johnson and Roberts, 2003; Liebscher et al., 2011; 
Roberts et al., 2006). In the NP tissue, progenitor cells 
are embedded in a tissue-specific microenvironment 
that significantly influences the their biological and 
metabolic processes (Hu et al., 2018). Low oxygen 





















fig. 3. summary of eCm-related components and their ranges within np microenvironment. It can be 
characterised by 4 main aspects: (i) water, (ii) proteoglycans, (iii) collagen type II, and (iv) other minor 
components. 
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nutrient supply are characteristics of the specialised 
IVD microenvironment. The level of specialisation 
and complexity of this microenvironment could 
be challenging for cell survival and health of 
endogenous progenitor or future implanted cells 
(Sakai and Andersson, 2015).
 An indigenous progenitor cell population that 
expresses an endothelial specific marker, i.e. Tie2 
(angiopoietin-1 receptor or CD202b), has been 
identified in human and murine NPs (Sakai et 
al., 2012). These Tie2+ cells were identified as the 
precursors of NP cells that further differentiate and 
start to express other surface markers, including 
GD2 and CD24 (Sakai et al., 2012). Moreover, 
Tie2+ cells have the ability of cell renewal (Sakai et 
al., 2012), and multi-potency with differentiation 
towards neurogenic, osteogenic, chondrogenic, and 
adipogenic lineages. The number of Tie2 positive cells 
in the human (Sakai et al., 2012) and mouse (Bach et 
al., 2016) NPC populations also decreased, not only 
during ageing but also with the progression of IVD 
degeneration. The specific factors responsible for an 
in vivo decrease of NP cell clustering and a reduced 
percentage of NP progenitor cells with age, or during 
a degenerative state, are not fully understood. One 
of the advanced explanations is that cell mortality 
associated with decreased nutrient oxygen and 
glucose transport in IVD induces the decrease of both 
cell clustering and the percentage of Tie2+ cells present 
in NP tissue (Urban and Roberts, 2003). Others have 
demonstrated that NP progenitor cells harvested 
from patients with degenerated IVDs still have 
similar cell colony-forming ability, proliferation rate, 
cell cycle, and trilineage differentiation properties to 
bone marrow stromal cells (Li et al., 2017a).
 Even NP progenitor cells derived from degenerated 
IVDs still retain their regeneration ability. They 
may be a promising cell candidate for cell-based 
regenerative medicine and tissue engineering for 
IVD degeneration. These results suggest that Tie2+ 
NPCs could play a crucial role in IVD regeneration, 
knowing that – even if their microenvironment is 
disrupted – they do not seem to be affected (Sakai et 
al., 2012). However, even if Tie2+ NPCs seems to be 
the “ideal candidate”, future strategies for NP tissue 
engineering and regenerative medicine should not 
only be focused on those cells as their numbers are 
very limited (around 1 %) in human IVD tissue (Hu 
et al., 2018).
how changes in their surroundings can alter np 
cells
Influences of non-ECM related factors on IVD 
progenitor cells
One intrinsic characteristic of progenitor disc cells 
is that they reside under hypoxic conditions due to 
a blood-supply shortage in the IVD and especially 
in the NP tissue. Under low-oxygen levels, the NP 
progenitor cells proliferate better than ASC, and 
their potential to differentiate on the chondrogenic 
lineage is increased (Li et al., 2013). Physiological 
hypoxia (2-5 %) seems to be the normal and the 
physiological environment for optimal functioning of 
IVD progenitor cells (Chen et al., 2014; Gantenbein et 
al., 2014; Stoyanov et al., 2011). However, invasion of 
blood vessels through fissures is generally observed 
during the process of IVD degeneration, which 
potentially increases the oxygen concentration and 
consequently aggravates the physiological hypoxic 
microenvironment of the IVD progenitor cells even 
further (Freemont et al., 2002; Nerlich et al., 2007). 
Therefore, in the context of cell therapy, restoring 
the hypoxic microenvironment may favour the use 
of NP progenitor cells.
 E x c e s s i v e  m e c h a n i c a l  l o a d i n g  a n d 
impaired biomechanics can be another crucial 
microenvironmental factor influencing NP progenitor 
behaviour (Chu et al., 2018; Desmoulin et al., 2020). 
For example, several studies showed an essential 
correlation between the presence and the severity 
of disc degeneration in obese or overweight adults 
(Lidar et al., 2012; Samartzis et al., 2012). Nevertheless, 
at a cellular level, the biomechanical factors display 
a wide range of impacts on the biological functions 
of NP progenitor cells. Recently, in vitro studies 
have shown that static compression stress induces 
mitochondrial apoptosis in NP progenitor cells (Li et 
al., 2018; Yuan et al., 2018). Apart from the induction 
of apoptosis and senescence, stress stimuli seem to be 
critical for the normal functioning of progenitor cells 
(Hosseini et al., 2015; Kobayashi et al., 1989; Zhao et 
al., 2015). As an illustration of this, fluid-shear stress 
can give rise to overexpression of ECM components 
synthesised by AF progenitor cells (e.g. Collagen type 
I and MMP-1) (Chou et al., 2016) – demonstrating 
the “double-edged sword” effects of applied forces 
on IVD cells and especially NP progenitor cells. 
To investigate these effects further, studies should 
focus on exploring various methods to protect 
IVD progenitor cells from excessive mechanical 
loading-induced dysfunction and increased cell 
death. Optimising mechanical stimulation of in 
vitro cultured IVD progenitor cells (also using Tie2+) 
could be used to produce a matrix mimicking the 
microenvironment and to explore in more detail the 
relationship between ECM composition, mechanical 
forces, and cell behaviour.
 Another non-ECM-related factor that can 
drastically influence NP progenitor cells (endogenous 
or implanted) seems to be osmolarity. Nevertheless, 
publications associating osmolarity and NP progenitor 
cells are still limited. Tao et al. (2013) pioneered the 
investigation of the influence of osmolarity on IVD 
progenitor cells. They found that high osmolarity 
in NP progenitor cells could decrease the viability, 
proliferation, and gene expression levels of not only 
the transcription factor SOX-9 but also aggrecan, and 
collagen type II, the two main components of the NP 
ECM.
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 Regarding the influences of non-ECM related 
factors on NP progenitor cells, it is necessary to 
examine the microenvironment pH. To have a 
comparison with already well-described cells, ASCs 
were used. Under low pH the proliferation and 
viability of the NP progenitor cells are better than 
those of ASCs (Han et al., 2014). More recently, it 
was shown that the acid-sensing ion channels in NP 
progenitor cells play a vital role in low-pH induced 
apoptosis, and the downregulation of stem-cell-
related genes (e.g. Oct4, Nanog, Jagged, Notch1) 
and ECM synthesis (e.g. aggrecan, SOX-9, collagen 
type I and collagen type II) (Liu et al., 2017). It is 
also known, in connection with Diabetes mellitus 
or hyperglycaemia, that an excess of glucose has 
negative effects upon NP progenitor cell biology 
(Liu et al., 2020). A comparison of NP progenitor cells 
cultured in low- or high-glucose media demonstrated 
that high glucose concentration significantly 
decreases cell proliferation, colony-formation ability, 
migration, and wound-healing capability. Moreover, 
NP progenitor cells from high-glucose culture also 
show significantly decreased expressions of a variety 
of markers, including SIRT1, SIRT6, HIF-1α, GLUT-
1, and caspase-3. Altogether, these data show that 
high levels of glucose might drastically impact NP 
progenitor cell behaviour (Liu et al., 2020).
Influences of ECM related factors on IVD 
progenitor cells
With the degeneration process of IVDs, the imbalance 
between ECM anabolism and catabolism intensifies 
the tissue dysfunction (Feng et al., 2016; Kepler et al., 
2013). When investigating NP progenitor cells in vitro, 
the importance of the ECM in the original tissue is 
not usually considered. However, the crosstalk and 
interaction between cells and the ECM are essential 
in affecting not only the morphology and phenotype 
but also the function of progenitor cells, as shown 
in NP tissue (Guilak et al., 2009; Rastogi et al., 2009). 
Perlecan, the common component of many stem cell 
niches, is produced by progenitor cells located in the 
NP tissue (Brown et al., 2018; Schlotzer-Schrehardt et 
al., 2007). It was previously found to play a decisive 
role in the chondrogenic differentiation of the IVD 
mesenchymal progenitor cells (Shu et al., 2013; 
Smith et al., 2010). Most importantly, changes to 
ECM mechanical strength in degenerated discs are 
transmitted to the cell membrane and consequently, 
by means of perlecan or other components of stem cell 
niches, activate the IVD progenitor cells (Subramony 
et al., 2013; Wang and Chen, 2013).
 The Piezo1 ion channel, which acts as a 
mechanosensor between the ECM and cells, is 
found in human NP cells to be involved in the 
pathway that starts with mechanical force sensing 
and results in cell apoptosis. The signal is mediated 
through mitochondrial dysfunction and endoplasmic 
reticulum stress (Li et al., 2017b). Nevertheless, many 
other aspects of mechanical sensing could potentially 
affect the behaviour of progenitor cells. How these 
IVD progenitor cells respond to them will require 
further investigation.
 Specific components of the ECM seem to have a 
greater impact than the others on NP cells. Laminin 
recently attracted the attention of researchers, as 
it is present in healthy NP tissue, but absent in 
degenerating NP tissue (Chung and Mercurio, 2004; 
Foldager et al., 2016; Foldager et al., 2014; Mercurio et 
al., 2001; Sun et al., 2017). Moreover, laminin receptors 
(α6β1 and α6β4 integrins) are known to improve cell 
survival in response to microenvironmental changes 
such as low oxygen tension or serum-deprivation (Gu 
et al., 2002), both relevant to NP tissue (Chen et al., 
2009).
 Another critical aspect of the microenvironment 
that can drastically influence the behaviour of NP 
progenitor cells is the inflammatory process occurring 
during IVD degeneration. Cytokines, such as IL-1β 
and TNF-α, are generally considered to be the key 
mediators of the IVD degenerative process and 
LBP (Burke et al., 2002; Risbud and Shapiro, 2014; 
Wang et al., 2020b). They are also upregulated in the 
degenerative IVDs, and they are closely related to 
various pathological IDD processes, including the 
inflammatory response, matrix destruction, cellular 
senescence, autophagy, apoptosis, pyroptosis, and 
proliferation. Conversely, IL-1β suppression prevents 
disc degeneration (Genevay et al., 2009; Le Maitre 
et al., 2007). Therefore, anti-IL-1β and anti-TNF-α 
therapies may have the potential to stop this vicious 
cycle present in disc degeneration and LBP. Knowing 
that IL-1β and TNF-α inhibition have the potential 
to alleviate IDD, an in-depth understanding of the 
role of IL-1β and TNF-α in IDD will benefit the 
development of new treatment methods for disc 
degeneration.
 The microenvironment of the native and, by 
extension, of degenerated IVD remains an important 
factor in the development of effective regenerative 
therapies (Baumgartner et al., 2021), presenting a 
challenge not only for the application of cell therapies 
but also for interventions based on growth factors, or 
other biologicals such as drugs, and biomaterials.
Tissue engineering and regenerative medicine for 
np tissue
A common way to improve or replace the function 
of biological tissue by tissue engineering is to use 
a scaffold (as a vehicle or a tissue replacement) in 
combination with cells that possess a regenerative 
potential, and/or additional components (chemicals, 
growth factors, oxygen priming, etc.). In the context 
of IVD tissue engineering, both the biological and 
mechanical properties of the scaffold will affect the 
biocompatibility within IVD tissue. Mimicking the 
microenvironment in the closest way possible will 
determine the in vivo function and regenerative 
potential of progenitor cells and determine the 
efficiency of IVD regeneration (Choi and Harley, 2012; 
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Engler et al., 2007; Hsieh and Twomey, 2010; Seliktar, 
2012). Utilising the natural molecules present in the 
IVD ECM could be an excellent starting point for 
the generation of scaffolding material, but synthetic 
polymers also seem to be efficient. Moreover, 
macromolecules present in the microenvironment 
could also be implemented or functionalised into an 
engineered scaffold in order to be even more similar 
to NP tissue. All those strategies will be presented in 
the following section.
related to non-eCm factors
As discussed in the previous section, the components 
of the microenvironment from native and degenerative 
IVDs are well known to drive and affect the survival, 
behaviour, and fate of endogenous or transplanted 
NP cells. In the following part, non-ECM factors 
used for tissue engineering approaches for NP 
regeneration are described (Table 1).
 One of the key components of the IVD 
microenvironment described above is the low pH. An 
acidic environment is vital for the maintenance of NP 
cells’ activities. However, changes in the acidity of the 
environment on human NP cells can be detrimental. 
To overcome this problem, it has been shown that NP 
progenitor cells cultured in presence of amiloride, an 
acid-sensing ion channel blocker, could significantly 
improve their proliferation, expression of stem cell-
related genes, and functional genes (Liu et al., 2017).
 As described above, the variation of osmolarity 
(osmotic concentration) can have a significant impact 
on the function and behaviour of NP cells. GAG has a 
key role in regulating osmolarity, therefore targeting 
this component of the microenvironment could be 
a critical element in improving tissue engineering 
approaches for NP repair and regeneration. For 
this reason, Sivan et al. (2014b) decided to develop 
a biomimetic GAG analogue-engineered scaffold 
based on sulphonate-containing polymers. The 
in vivo delivery of this biomimetic GAG, which 
can polymerise in situ, was used in a porcine 
and bovine degenerate explant model and, as a 
result, demonstrated the ability of the implanted 
hydrogel to restore NP tissue stiffness. Hydrogels 
or engineered scaffolds mimicking GAG function 
in vivo while maintaining disc hydration and height 
could be a solution for NP tissue repair or helping 
its regeneration by restoring part of the native 
microenvironment.
 Another critical point for NP tissue engineering 
could be that cells in vitro primed in a low oxygen 
environment could then also promote an NP 
phenotype in vivo. As an example, Feng et al. 
(2014), cultured NP bovine cells for 3 weeks in a 3D 
environment with different oxygen tension levels 
(2 % to 20 %). They demonstrated that, even after 8 
weeks of in vivo implantation, the hypoxic priming 
of NP cells resulted in the maintenance of GAG, 
collagen type II, aggrecan, and SOX-9 expression 
compared to normoxic priming. The maintenance 
of the NP phenotype was therefore achieved if cells 
were originally cultured under hypoxic conditions 
before implantation. In summary, combining hypoxia 
with a relevant scaffold could enhance NP function 
after implantation. Moreover, hypoxia induction of 
NP cells should be applied to most of the strategies 
to successfully regenerate NP tissue for IVD repair.
 Researchers also found that SLRPs – bioactive 
components of the ECM – were associated with 
fibrillogenesis, cellular growth and apoptosis, as well 
as tissue remodelling of the IVD. They can support 
the survival of IVD progenitor cells under hypoxic 
conditions by the activation of specific hypoxia-
inducible factors (Chen et al., 2017). As a result, agents 
that can stimulate the production of SLRPs (e.g. 
biglycan or decorin) might help NP progenitor cells 
to survive under hypoxic conditions (Huang et al., 
2013) and could become critical components for the 
niche, providing new approaches to use the biology 
of the microenvironment as a toolbox (Rajasekaran 
et al., 2021).
 Recently, a new approach was developed for 
the sequential release of chemokines followed by 
growth factors, using a delivery system based on 
polysaccharide microbeads (Frapin et al., 2020). In 
the pullulan-based scaffold, CCL-5 was first used 
to attract cells with a regenerative potential into NP 
tissue. After this first phase of recruitment, TGF-β1 
and GDF-5 were chosen as growth factors to induce 
the synthesis of an ECM rich in collagen type II and 
aggrecan, in vitro. The authors then proceeded to ex 
vivo experiments using the same delivery system in 
degenerated ovine IVDs. As a result, after histological 
analysis, they observed an increase of NP cellularity 
and more collagen type II, and aggrecan. Moreover, 
the amount of Tie2+ positive cells (NP progenitor) 
was higher compared to the control condition. The 
sequential delivery of macromolecules to repair 
and regenerate the ECM could be a strategy for 
functionalised engineered scaffolds in the future.
 Concerning the GAG, trying to increase their 
expression in vivo after implantation can be one 
element to target – by the use of an engineered 
scaffold, as already described. However, trying to 
reduce its degradation in vivo can also be a way 
to improve the success rate after implantation. In 
this context, several in vitro studies have shown 
that glucosamine has an inhibitory effect on the 
degeneration of proteoglycans, providing the 
potential of a NP tissue engineering application in 
the context of IVD degeneration (Ilic et al., 2003; 
Munteanu et al., 2002; Samiric et al., 2006). A novel 
deacetylated poly-N-acetyl glucosamine hydrogel, 
as a potential therapy for treating NP degeneration, 
has also been developed (Gorapalli et al., 2012). 
Using primary human cells, they showed an increase 
in cell viability, metabolic activity, proteoglycan 
synthesis, and ECM protein expression (aggrecan 
and collagen type II). This hydrogel has promising 
in vitro characteristics and motivates further in vivo 
evaluation as a potential therapy for NP degeneration 
of the IVD.
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Table 1a. Tissue engineering strategies with non-eCm related factors for np. Microenvironment modulation.
 The fabrication/development of scaffolds with 
chondroprotective supplementation could be an 
interesting approach to avoid straying any further 
from the microenvironment of the NP tissue, in case 
of degeneration. Using a combination of alginate 
and CaCl2 (in a w/v ratio of 2 % and 0.025 mol/L, 
respectively), supplemented with glucosamine 
hydrochloride and chondroitin sulphate A, Foss et al. 
(2014) showed an improvement in both mechanical 
and biochemical properties of the engineered 
hydrogels. However, although the promising results 
come from a 28-day study with human NP cells, they 
are only in vitro. Therefore, in vivo studies appear 
as a necessity to confirm their validation for future 
applications in the field of regenerative medicine as 
applied to NP tissue.
 Recently, many factors that are able to influence 
the native microenvironment by modulating IVD 
metabolism in vivo were listed (Yang and Li, 2009). 
Growth factors could be used as a biological treatment 
choice for intervertebral disc degeneration (Paesold 
et al., 2007). Studies using IGF-1, PDGF, or BMP-7 
for their effects on apoptosis inhibition in IVD cells 
can also be listed (Gruber et al., 2000; Wei et al., 2008). 
However, the purpose of adding single growth factors 
(Chujo et al., 2006; Cui et al., 2008; Gilbertson et al., 
2008; Hodgkinson et al., 2020; Kawakami et al., 2005; Li 
et al., 2004; Masuda et al., 2006; Tsai et al., 2007; Walsh 
et al., 2004) or a combination of them (Akyuva et al., 
2019; Henry et al., 2017; Hou et al., 2016; Liang et al., 
2012b; Sun et al., 2021) is mostly to stimulate the IVD 
metabolism through GAG, collagen or non-collagen 
synthesis.
 For successful implantation of tissue engineering 
scaffolds and/or cells within the NP tissue, another 
angle of attack could be to reduce the inflammation 
to get closer to the IVD anabolism and native 
microenvironment. To reach this target, the efficacy 
of intradiscal controlled release of TAA, an anti-
inflammatory drug, in a preclinical degenerated IVD 
model has been evaluated (Rudnik-Jansen et al., 2019). 
Another team, using the same approach but using 
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celecoxib, obtained similar results. This prevented 
progression of IVD degeneration both in vitro by 
promoting the function of implanted progenitor cells, 
and in vivo by preserving water content and integrity 
of collagen fibres (Tellegen et al., 2018). More recently, 
the use of ligustrazine showed interesting results in 
the reducing the expression of inflammatory factors 
by the suppression of TGF-β overactivation in NP 
cells (Liu et al., 2019). Besides tipping the balance 
toward a healthier microenvironment, the anti-
inflammatory factor related strategies can also be 
beneficial for pain relief in patients undergoing LBP 
(Fontana et al., 2015).
related to eCm factors
Biomaterials (scaffolds, hydrogels, etc.) based on 
native NP ECM components could provide the 
missing link for the functional support of exogenous 
or native cells. The different application, with their 
biological and mechanical influence on IVD cells 
(Table 2), is presented below.
 Laminin seems to play a relatively important 
role in NP tissue, as NP cells are known to cluster 
and produce more GAG rich ECM when cultured 
on soft (< 0.5 kPa) laminin-rich substrates, compared 
to fibronectin or collagen enriched ECM (Hwang et 
al., 2014). Therefore, laminin supplementation has 
already improved musculoskeletal regeneration in 
several models of disease and injury (Marcinczyk 
et al., 2017). Implantation of a PEG hydrogel, 
functionalised with laminin, into the NP in vivo 
resulted in more implanted cells remaining after 
14 d as well as an increased viability (Francisco et 
al., 2013). Moreover, cultured NP cells within this 
PEG hydrogel and functionalised with laminin were 
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Table 1b. Tissue engineering strategies with non-eCm related factors for np. Single growth factors.
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Table 1c. Tissue engineering strategies with non-eCm related factors for np. Multiple growth factors and 
anti-inflammatory strategies. 
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Table 2a. Tissue engineering strategies with eCm related factors for np. Laminin and collagen related.
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Table 2b. Tissue engineering strategies with eCm related factors for np. SAPH related and decellularised 
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expression of N-cadherin and cytokeratin 8 (Francisco 
et al., 2014). Both studies provide evidence that the use 
of laminin in engineered scaffolds could positively 
influence NP cell proliferation and function and 
should be studied in more detail to improve NP tissue 
engineering strategies.
 Another vital component of IVD ECM that can 
be used as scaffolding material is collagen and 
particularly collagen type II (Zhou et al., 2018). This 
main ECM component promotes the differentiation of 
NP progenitor cells, especially into the chondrogenic 
lineage (Tao et al., 2016). When collagen type II 
is used at high concentrations for the scaffolding 
material, ASCs express a high level of collagen 
type II, aggrecan, SOX9, and low levels of collagen 
type I in response (Fontana et al., 2014; Tao et al., 
2016). Collagen (mainly type II) should be used 
as the only and main component of the scaffold. 
Its implementation at a significant level should be 
enough to generate advantages such as enhancing 
cell migration and proliferation in porous scaffolds, 
which could be used for implemented tissue repair 
strategies (Guillaume et al., 2015; Huang et al., 2011; 
Sakai and Grad, 2015; Sarker et al., 2015; Yang and Li, 
2009).
 Merging/combining most of the components of the 
NP microenvironment – such as elastin, collagen, and 
GAG – within a unique engineered scaffold/hydrogel 
could be a huge step towards successful NP tissue 
engineering applications. A chemically-stabilised 
elastin-GAG-collagen composite hydrogel shows 
great in vivo biocompatibility potential, with host cell 
infiltration and active remodelling of the NP tissue, 
after 4 weeks of in vivo subcutaneous implantation 
in rats (Mercuri et al., 2014). Studies should now 
investigate the feasibility of this composite hydrogel 
for the replacement and regeneration of the NP.
 Very recently, short SAPHs have attracted 
significant interest as they can mimic the natural ECM 
of the targeted tissue, holding significant promise for 
the ab initio design of the cellular microenvironment 
(Ligorio et al., 2019). Moreover, SAPHs are beneficial 
mechanically, as they present a strength comparable 
to the native NP tissue, are injectable, can restore the 
IVD cell phenotype, and stimulate the deposition 
of appropriate ECM components (Wan et al., 2016). 
These hydrogels open up new possibilities as they can 
be perfectly integrated into the NP microenvironment 
and offer the possibility of being customised by 
functionalisation (Wang et al., 2012).
 Another approach, that has appeared recently, 
is the use of decellularised matrices instead of 
combining several main components. These matrices 
preserve the NP ECM biological components and 
microstructure and, therefore, should perfectly 
mimic the NP microenvironment (Yu et al., 2020; 
Yuan et al., 2013). A protocol for the decellularisation 
of porcine NP tissue has been developed, which 
results in a decrease in IVD degeneration following 
in vivo implantation (Xu et al., 2019). This, naturally 
derived, bioactive ECM material could serve as a 
potential treatment option for degenerated discs 
(Borrelli and Buckley, 2020). Nevertheless, it still 
needs to be investigated in a human setting or for 
GMP rules. However, very recently and for the first 
time, the creation of decellularised whole human IVD 
with attached bone was achieved (Hodgkinson et al., 
2020). Further investigations are required before this 
technology can be taken forward as an implantable 
regenerative solution for IVD replacement in clinical 
applications.
 In conclusion, key components of the NP 
microenvironment from an IVD play an important 
role in ongoing and future approaches for NP 
tissue engineering. The use of components that are 
already present in the native microenvironment 
seem to have a high rate of success. However, 
the development of scaffolds based on natural 
materials such as silk (Park et al., 2012), alginate (Du 
et al., 2019), chitosan (Alinejad et al., 2019; Yuan et 
al., 2019) or gellan gum (Silva-Correia et al., 2011; 
Tsaryk et al., 2017) also show good results but are 
more different from native components. Interesting 
and positive effects demonstrated by those different 
strategies, to promote IVD and NP regeneration, 
rely on the concept of optimally mimicking the 
microenvironment requiring treatment, and remain 
to be further elucidated (Guilak et al., 2009).
 Although synthetic scaffolds can provide 
functional support for progenitor cell transplantation, 
their mechanical influence on IVD progenitor cells 
should not be neglected (Melrose, 2016). The elasticity 
of a scaffold can influence the differentiation of 
progenitor cells (Zhu et al., 2016); for example, a stiff 
synthetic matrix can promote osteogenesis and inhibit 
chondrogenesis of NP progenitor cells (Navaro et al., 
2015). Therefore, biomaterials should be designed 
with appropriate elasticity and stiffness to facilitate 
progenitor cell function.
The clinical problem – still in between bench and 
bedside
LBP compromises a complex of symptoms with 
varying underlying pathologies, including micro- 
and macro-instability, disturbing of neurological 
structures, and degeneration of facet joints, 
inflammatory conditions, neoplasm, and deformity. 
A widely accepted concept considers the IVD itself as 
the generator of pain, which is referred to as discogenic 
pain. However, the underlying biochemical or 
physical patho-mechanisms of LBP related solely 
to the IVD remain mostly unclear. Moreover, many 
patients with radiological abnormalities of the IVD 
do not suffer any clinical symptoms (Boden et al., 
1990). Several in vitro studies found an upregulation 
of inflammatory markers such as TNF-α and IL-1β in 
patients with suspected discogenic LBP. Histological 
studies revealed the ingrowth of nerves and vessels 
into the IVD. This could be the beginning of a 
degenerative cascade (Mosley et al., 2017), with pain 
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signals transmitted continuously into the central 
nervous system. Thus, patients perceive pain because 
of the IVD-degeneration progression.
 Despite these observations from in vitro and 
preclinical studies, the clinical diagnosis of discogenic 
pain is difficult. A possible approach to the diagnostic 
scheme for patients with suspected discogenic 
LBP is provocative discography. After puncturing 
the AF with a thin needle, saline and fluoroscopic 
agents are injected, increasing intradiscal pressure. 
Subsequently, the provocation of typical pain 
confirms the diagnosis of discogenic LBP. Drawbacks 
of provocative discography include the absence of 
objective findings with the positive result relying 
purely on subjective perception and response of 
the individual patient. Moreover, several studies 
demonstrated an acceleration of IVD degeneration 
following discography, likely as a result of iatrogenic 
AF injury during the procedure (Carragee et al., 2009; 
Cuellar et al., 2016). Therefore, the use of provocative 
discography as a diagnostic test has diminished 
recently.
 In cases where discogenic pain is suspected to 
be the underlying cause of LBP in a clinical routine, 
patient treatment focuses on the management of 
symptoms and not on addressing the underlying 
pathomechanisms. First-line therapy of patients 
with pain related to IVD degeneration consists 
of conservative treatment modalities, including 
physiotherapy and pain management with non-
steroid anti-inflammatory drugs, opioids, or 
epidural steroid injections (Airaksinen et al., 2006). 
If conservative management fails, surgical treatment 
is often performed. The most common surgical 
intervention of degenerative disc disease is IVD 
removal, replacement with implants, and fusion 
using bone grafting to permanently connect two or 
more vertebrae of the spine.
 Based on laboratory and preclinical findings, 
IVD-maintaining surgical approaches have been 
increasingly studied recently. Attempts to address 
IVD regeneration invasively comprise a variety of 
techniques that specifically aim at modulating the 
degeneration cascade of the IVD (Fig. 4). Access to 
the IVD to apply these techniques is either achieved 
by intradiscal injection or minimally-invasive or 
open-surgical approaches. However, only a few 
methods have made their way into clinical practice. 
A brief overview of ongoing clinical trials of the most 
promising strategies will now be provided, focussing 
on the ECM, and concentrating upon cell-based 
therapies, growth factors, and biomaterials.
Cell-based therapies
The cell-based therapy approach (Table 3) utilises the 
transplantation of cells into the IVD by puncturing 
the AF. The injected cells release anti-inflammatory 
factors/secretome and produce ECM (Wangler et al., 
2019). Theoretically, this leads to IVD regeneration, 
with reduced pain and improved function, for the 
patient.
 There are mainly 5 categories of cell sources 
used to treat IVD degeneration: (1) IVD-derived 
cells, (2) chondrocyte-like cells, (3) MSCs, (4) iPSCs, 
and (5) ES cells (Sakai and Schol, 2017). By far, most 
published studies and ongoing clinical trials focus 
on MSCs (Table 3). However, any clinical evidence 
for positive effects still remains unclear. What has 
already been shown is that most of these procedures 
are safe (Orozco et al., 2011; Wei et al., 2014). The most 
often used donor site of autologous MSCs is the iliac 
crest, meaning an additional invasive procedure 
for the patient. The harvested cells are then either 
directly injected or grown in the lab and subsequently 
reinjected into the IVD. A meta-analysis of 6 studies 
(using either MSC or chondrocytes) showed an 
improvement of pain in the ODI as an outcome 
parameter for function (Wu et al., 2018).
fig. 4. overview of the most recent applications used for clinical trials in the context of degenerative 
ivds and lbp. Clinical therapies can be divided into 3 different strategies: (i) cell-based with the use of 
IVD-derived cells, chondrocyte-like cells, MSCs, iPSCs or ES cells, (ii) growth factors-based with the use 
of GDF-5 or PRP and to finish, (iii) biomaterials-based with the use of Gelstix™ hydrogel, Biostat Biologx® 
fibrin sealant and VAST. 
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 A meta-regression analysis identified a significant 
preference for MSC over chondrogenic cells (Schol 
and Sakai, 2019; Wu et al., 2018). Because of the need 
for high-quality clinical data, the RESPINE-project 
was funded by the European Union’s funding 
programme for research and innovation, Horizon 
2020. The project started in 2017 and aimed at 
verifying the efficacy of an allogeneic intervertebral 
MSC-based therapy by providing a high-level clinical 
trial, including 112 patients with pain related to disc 
degeneration. No results have yet been published.
Growth factors
Injection of growth factors could support homeostasis 
of IVD cells and, therefore, enhance disc regeneration. 
In addition to many in vitro and animal studies 
(Kennon et al., 2018) there are only a few ongoing 
clinical trials (Table 4). A multicentre, randomised, 
blinded, and placebo-controlled trial, provided by 
DePuy Synthes, investigated the effect of rhGDF-5. 
The results, posted on clinicaltrails.org (Web ref. 
17), showed a higher dosage of rhGDF-5 (2.0 mg/
disc) with an improvement in pain and quality of life 
measurements but it also had a higher risk profile 
with more (serious) adverse events (Kennon et al., 
2018).
 As a combination of different growth factors, 
PRP that has been already studied extensively for 
cartilage regeneration, has also been studied for 
LBP. Even though it seems to be a safe procedure 
(Levi et al., 2016; Tuakli-Wosornu et al., 2016), results 
from a prospective, non-randomised trial revealed 
a relatively low-success rate (pain and ODI) under 
50 % (Levi et al., 2016). Moreover, a prospective, 
randomised-controlled study on intradiscal PRP 
injection showed an improvement of pain and 
function after a one-year follow-up (Tuakli-Wosornu 
et al., 2016). Nevertheless, adequately designed 
randomised controlled trials are still needed to clarify 
the safety as well as long-term benefits of intradiscal 
PRP injection (Buser et al., 2019).
drugs
With the various mechanisms associated with IVD 
degeneration in mind, some current research and 
clinical applications have focused on different 
approaches for pain treatment and/or reversing 
disc degeneration. One aspect is the application of 
drugs. In addition to analgesics, which with their 
low molecular weight are often used as a first resort 
to relieve LBP associated with IVD degeneration, 
various novel treatments are also being evaluated in 
preclinical models (Cherif et al., 2020; Cunha et al., 
2020; Hu et al., 2019; Wang et al., 2020a). Among these, 
inflammatory cytokine and enzyme inhibitors are 
frequently used as therapeutic agents, but so far these 
agents have shown no or only limited effectiveness 
and an increased risk of adverse events (Tryfonidou et 
al., 2020). However, several clinical trials are ongoing 
targeting different critical points of the diseased 
microenvironment (Table 5).
biomaterials
One major problem that must be addressed for 
regenerative strategies of the IVD is the loss of the NP 
water content. The dehydration of the IVD tissue is 
an early sign of disc degeneration, seen as a so-called 
“black disc”, with low water content and, therefore, a 
dark instead of a light NP, in MRI images (Pfirrmann 
et al., 2001). Consequently, hydrophilic materials such 
as hydrogels that might compensate for the decreased 
water content have been extensively studied both 
in research (Buckley et al., 2018) and clinical trials 
(Table 6).
 The origin of the hydrogels can either be natural 
or synthetic. Natural hydrogels (including alginate, 
collagen or fibrin-clot) can serve as a cell-carriers 
(e.g. for MSCs) by providing a 3D cytocompatible 
environment. However, their inferior mechanical 
properties are a significant disadvantage (Frauchiger 
et al., 2017; Peroglio et al., 2013). Synthetic hydrogels, 
on the other hand, have better mechanical properties. 
Such gels are, for example, the thermo-responsive 
hydrogel pNIPAM, PEG or the very promising group 
of silk scaffolds. Frauchiger et al. (2017) reviewed 
the different hydrogels in detail. For clinical use, 
such a formulation needs to be injectable and has 
to be applied intradiscally by a minimally invasive 
approach. However, there are only a few studies on 
such injectable materials for humans (e.g. GelStix™, 
an intradiscal admitted hydrogel) (Ceylan et al., 
2019). A randomised, placebo-controlled, multicentre 
study indicated a significant reduction of pain, 
function, and high patient satisfaction (Ceylan 
et al., 2019). Also, internal disruption of the disc 
can be found in degenerated IVDs. Therefore, a 
clinical study investigated the intradiscal injection 
of fibrin sealant (Biostat Biologx®) (Yin et al., 2014). 
A prospective placebo-controlled pilot study with a 
two-year follow-up demonstrated a safe application 
and improved pain and function (Yin et al., 2014). 
The VAST clinical trial aimed to safely supplement 
tissue loss to degenerate IVDs. By injection of a 
supplemental viable disc matrix, improved pain, and 
function at one-year was achieved (Beall et al., 2020).
 Despite all these increasing efforts to investigate 
degenerative processes in the IVD and straight-
forward clinical trials, translation into everyday 
clinical practice with a direct impact on patient 
management is sparse. Moreover, care must be 
taken to measure the outcome parameters. Most 
of the studies mentioned above did not include 
any radiographic, especially MRI imaging, in their 
outcome measures. Therefore, it is not possible to 
assume the influence on the IVD microenvironment 
and especially restoration of the ECM.
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Conclusions
Healthy IVDs and especially their NP tissue 
are physiologically hypoxic, acidic, have a high 
osmolarity, and are poor in nutrient supplementation. 
These characteristics make this a very specific 
microenvironment in the human body but also 
sufficiently inhospitable for future implanted cells, 
if needed. This complex microenvironment can 
encounter many modifications/adjustments of non-
ECM-related and ECM-related factors that, as a 
result, affect NP cells – inducing function impairment. 
During disc degeneration, NP cells that have lost 
their ability to form functional and stable cell-cell 
and cell-ECM crosstalk may also lose their ability 
to produce specific ECM and ECM-related proteins. 
This contributes to the inability of the NP tissue to 
regenerate and self-repair and, therefore, the IVD 
itself. The NP cells are in perpetual interaction with 
the surrounding microenvironment and receive cues 
that help to regulate and maintain the NP phenotype 
through the behaviour of NP progenitor cells.
 Perfect knowledge of all the components of 
this microenvironment and how they interact with 
NP progenitor cells, could ultimately lead to the 
development of more efficient strategies able to 
reverse or at least slow down IVD degeneration. 
Being able to mimic, thus study and understand 
NP cell-ECM crosstalk gave rise to many new tissue 
engineering strategies with different rates of success. 
Partially recreating the microenvironment with one 
of the main ECM components (e.g. collagen type 
II, fibronectin, laminin, elastin, or GAG) did not 
show useful results for IVD repair or regeneration, 
as compared to engineered-scaffolds that combine 
many of them into one biomaterial. However, the 
best current approach –with outstanding potential 
for intervertebral disc regeneration – seems to be 
decellularised NP tissue, able to highly preserve 
structures and significant biochemical components 
of the native tissue.
 There has been a dramatic improvement in 
the understanding and “mastering” in the use of 
potential key factors of the NP microenvironment 
for regenerative medicine approaches in the 
previous decade. The implementation of already 
existing culture methods, with key factors such as 
hypoxic conditions or ECM related proteins, close 
the gap towards successful in vivo applications. All 
the components needed for the “reconstruction” as 
well as the regeneration of the NP tissue seem to be 
already present within the IVD microenvironment. 
Therefore, the microenvironment of the NP tissue can 
be rightly considered as its own fountain of youth in 
the treatment of degenerative disease and LBP.
 Understanding which factors are present in the 
IVD microenvironment and how they govern the IVD 
behaviour has not only scientific merit but also a huge 
translational value. New strategies, with the ability 
to harness these components/factors, have started 
to emerge and could provide a valid therapeutic 
option for future clinical management to treat DDD 
and more generally LBP. Future studies to further 
clarify the characteristics and functions of the IVD 
microenvironment in more detail and to mimic its 
function will facilitate IVD tissue engineering and the 
discovery of novel approaches for IVD regenerative 
medicine.
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Jivko stoyanov: In your review article you well 
describe the possible cell sources that can be used 
for the repair of degenerative disc disease (providing 
several references to published studies and clinical 
trials). If you had to choose one therapeutic cell type, 
which one would you select and why?
Authors: Various cell types are described in this 
review and have been used for IVD regeneration 
including IVD-derived cells, chondrocytes-like cells, 
mesenchymal stromal cells (MSCs), iPSCs, or ES cells. 
However, MSCs isolated from bone marrow or from 
adipose tissue have immunomodulatory functions, 
are more easily accessible for sampling, and can 
differentiate into cartilage. Therefore, they should 
be considered, on my point of view, as a potentially 
ideal cell source for IVD regeneration.
Jivko stoyanov: Would you point the top three factors 
of the NP microenvironment on which regenerative 
medicine approach should be concentrated in the 
next decade?)
Authors: From our point of view and according to 
the large literature cited in this review, the top three 
factors/components that must be taken from the NP 
microenvironment for regenerative purposes are the 
following ones. First, the use of hypoxic conditions 
to pre-accommodate (prime) the cells used in the 
approach, secondly a biomaterial able to mimic 
mechanical and physiological aspects of the NP, 
ideally decellularised ECM, and thirdly the possible 
addition of the most promising growth factor, GDF-5.
editor’s note: The Guest Editor responsible for this 
paper was Zhen Li.
